Go to Page # Page of 21
loading

Innovation in Allergy Immunotherapy

 Louis Champion, Michel Baijot, Yves Desiront
  26th-Jun-2019
Description: ASIT biotech treatments consist of a mixture of purified peptides from different selected sizes, produced from natural sources of allergens for allergy immunotherapy.
Views: 754
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: ASIT biotech
 ‐ More of their Presentations
weSRCH App on Apple
Contents:
INNOVATION IN ALLERGY
IMMUNOTHERAPY
INVESTORS PRESENTATION

APRIL 2019

Disclaimer
This presentation (“Presentation”) has been prepared by ASIT biotech (“ASIT”) to
provide an overview of the Company, it does not constitute a prospectus, an audit or
due diligence review and should not be construed as such. While the information
contained in this Presentation is believed to ... See more

Recent Presentations

...
22 July, 2019
Tine Peeters
21 July, 2019

FDA's Approach to the Opioids Crisis

FDA is working in a prioritized way in multiple areas to confront opioid overdoses while working to ensure patients receive appropriate pain treatment.

...
20 July, 2019